📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Nanoparticulate peptide delivery exclusively to the brain produces tolerance free analgesia. (2018)

First Author: Godfrey L

Attributed to: Technologies for the Treatment of Brain Diseases funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.jconrel.2017.11.041

PubMed Identifier: 29191784

Publication URI: http://europepmc.org/abstract/MED/29191784

Type: Journal Article/Review

Volume: 270

Parent Publication: Journal of controlled release : official journal of the Controlled Release Society

ISSN: 0168-3659